'This mendelian randomization study suggests that PCSK9 is implicated in psoriasis pathogenesis, and its inhibition is associated with reduced psoriasis risk. These findings potentially pave the way for future studies that may allow personalized selection of lipid-lowering drugs for those at risk of #psoriasis.'

https://jamanetwork.com/journals/jamadermatology/fullarticle/2800634?guestAccessKey=3aed40ad-0631-484f-a639-f3f6e33f2767&utm_source=linkedin_company&utm_medium=social_jamaderm&utm_term=9174110788&utm_campaign=article_alert&linkId=205542175